0000950170-24-004007.txt : 20240111 0000950170-24-004007.hdr.sgml : 20240111 20240111174308 ACCESSION NUMBER: 0000950170-24-004007 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240109 FILED AS OF DATE: 20240111 DATE AS OF CHANGE: 20240111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tan Kevin CENTRAL INDEX KEY: 0001884056 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38360 FILM NUMBER: 24530092 MAIL ADDRESS: STREET 1: 20 HICKORY ROAD CITY: WELLESLEY STATE: MA ZIP: 02482 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Solid Biosciences Inc. CENTRAL INDEX KEY: 0001707502 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 900943402 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 RUTHERFORD AVENUE STREET 2: 3RD FLOOR CITY: CHARLESTOWN STATE: MA ZIP: 02129 BUSINESS PHONE: 617-337-4680 MAIL ADDRESS: STREET 1: 500 RUTHERFORD AVENUE STREET 2: 3RD FLOOR CITY: CHARLESTOWN STATE: MA ZIP: 02129 FORMER COMPANY: FORMER CONFORMED NAME: Solid Biosciences, LLC DATE OF NAME CHANGE: 20170524 4 1 ownership.xml 4 X0508 4 2024-01-09 0001707502 Solid Biosciences Inc. SLDB 0001884056 Tan Kevin C/O SOLID BIOSCIENCES INC. 500 RUTHERFORD AVENUE, THIRD FLOOR CHARLESTOWN MA 02129 false true false false CFO & Treasurer false Common Stock 2024-01-09 4 M false 11250 A 13243 D Common Stock 2024-01-09 4 S false 3935 8.20 D 9308 D Restricted Stock Units 2024-01-09 4 M false 11250 0.00 D Common Stock 11250 33750 D Restricted stock units convert to common stock on a one-for-one basis. Includes 1,993 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on November 30, 2023. This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The sales do not represent a discretionary trade by Mr. Tan. The restricted stock units were granted on January 9, 2023 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. /s/ David Tyronne Howton as attorney-in-fact for Kevin Tan 2024-01-11